Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

Since I believe Leo would never publicize a trial end and future release of results without knowing the preliminary outcomes, B showed efficacy against CoV-2 in culture and will move to the next phase of testing. These results were too fast for in vivo studies examining both efficacy against CoV-2 infection as well as efficacy against inflammation. But, the next announcement will probably be approval to advance. Hopefully that will mean limited human testing, but could also be formulation for delivery followed by mouse or other quick, preclinical protocol.